课题基金 / 基金详情

5-HT是调控thrombopoietin合成的调节子?

批准号:
81770116
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
杨默
依托单位:
学科分类:
巨核细胞、血小板与相关疾病
结题年份:
2021
批准年份:
2017
项目状态:
已结题
项目参与者:
冯晓勤、伊文芳、梁恩瑜、张鑫、魏会灵

项目摘要

结项摘要

项目成果

杨默的其他基金

相似基金

相关文献

中文摘要
血小板生成素TPO生成调控是尚未解决的科学问题。目前认为肝肾产生TPO基本恒定,骨髓产生TPO可调节,但机制不清楚。我们基于对5-HT在调控巨核细胞系造血的原创性工作(Stem Cells,2007;2014)提出出血应激时血小板激活释出5-HT,作用于骨髓基质细胞(MSCs)5-HT2型受体,激活Erk1/2通路,在转录水平调控TPO生成之假说。本研究将验证:(1)MSCs表达5-HT2型受体,5-HT通过5-HT2型受体对MSCs发挥作用;(2)5-HT激活5-HT2受体和Erk1/2通路,在转录水平调节TPO合成;(3)5-HT促进微粒(MPs)释放和增加MPs中TPO含量。上述目标完成后,制作5-HTR2b Knock-out小鼠模型,进一步验证体外结果。本研究将证明血小板源性5-HT是否是TPO合成的调节子,为解答如何调控TPO的生成和指导临床使用TPO有重要的科学意义。
英文摘要
Thrombopoietin (TPO) is a major cytokine for megakaryopoiesis and platelet production. It is synthesized by liver, kidney and bone marrow stromal cells. However, how to regulate TPO production is still unclear. At present, it was found that liver and kidneys produce TPO consistently. And a proportion of total TPO is produced by stromal cells in the bone marrow and their TPO mRNA production is sensitive to factors produced by platelets and thus also linked to platelet number.   The mechanism of action remains unknown. Since serotonin (5-HT) can be released from the active platelets when the body undergoing bleeding or stress, it may functions as an essential hormonal mediator regulating TPO production...Here, we hypothesized that 5-HT exerts its effect through the binding of 5-HT 2 receptors, regulating TPO production in bone marrowl stromal cells (MSCs). In this study, we will test our hypothesis though three objectives:(1)To identify the expression of 5-HT2 receptors on MSCs of bone marrow;(2) To determine the role of 5-HT2 receptors and Erk1/2 signaling on TPO released from MSCs at mRNA and protein levels; (3)To investigate the impact of 5-HT on the production of TPO mRNA and protein contained within the MSCs –derived microparticles (MPs). Furthermore, the relationship between the plasma levels of 5-HT and TPO, and the expression of MSCs TPO mRNA of bone marrow in 5-HTR2b Knock-out mouse model will be studied...Results from this study may show that 5-HT stimulates TPO production from MSCs in both dissociative and MP-bounded form, which will help us to understand the physiological regulation of TPO production.
骨髓间充质细胞(MSCs)是骨髓造血微环境的重要组成部分,为血液细胞的生长和分化提供细胞支持和多种细胞因子。研究者认为,骨髓间充质细胞在外源性因素的影响下反馈调节骨髓TPO的合成和分泌,并且认为血小板分泌的因子可能参与了该调节过程。骨髓TPO的生成可能是由循环中血小板的某种感受机制触发的,但是具体机制仍不明确。循环中大部分的5-HT储存于血小板的致密颗粒中,血小板激活后会释放出大量的5-HT。有研究证实,5-HT既能促进巨核细胞的增殖和减少其凋亡,还能促进骨髓基质细胞成纤维细胞集落形成单位(CFU-F)的形成,其机制还不明确。5-HT对骨髓间充质细胞TPO的合成是否有影响,以及其机制是什么?因此,本研究提出假说:在创伤出血应激等情况下,血小板激活释放出5-HT,5-HT作用于微环境中骨髓间充质细胞,通过5-HT2受体,激活STAT3通路,增加TPO的生成。. 我们的研究发现,血小板来源的5-HT促进创伤性小鼠模型中TPO的产生;体外试验中,5-HT明显促进MSCs中TPO mRNA和蛋白的合成,其机制是通过5-HT2B受体,促进STAT3的磷酸化,并能够增加MSCs微粒的释放及微粒中TPO的含量。此外,我们证实5-HT通过FAK/Rho A/ROCK信号通路及调控F-actin重组调控微粒的释放。. 由于如何调节血小板生长因子 TPO 的产生是尚未解决的科学问题,希望本研究能够提供更多有助于解决该生理学问题的证据;5-HT是一种神经递质,目前的研究结果将有助于阐明神经系统可能通过神经递质在调节造血中的作用。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Melatonin protects against apoptosis of megakaryocytic cells via its receptors and the AKT/mitochondrial/caspase pathway
褪黑激素通过其受体和 AKT/线粒体/半胱天冬酶途径防止巨核细胞凋亡
DOI: 10.18632/aging.103483
发表时间: 2020-07
期刊: Aging-US
影响因子: 5.2
作者: [Yang Mo, Li Liang, Chen Shichao, Li Suyi, Wang Bo, Zhang Changhua, Chen Youpeng, Yang Liuming, Xin Hongwu, Chen Chun, Xu Xiaojun, Zhang Qing, He Yulong, Ye Jieyu]
通讯作者: Ye Jieyu
Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019.
患有心血管相关合并症的老年男性死亡率较高:对 602 名 2019 年冠状病毒病患者进行的回顾性研究
DOI: 10.3389/fcvm.2021.680604
发表时间: 2021
期刊: Frontiers in cardiovascular medicine
影响因子: 3.6
作者: [Zhan XY, Li L, Hu Y, Li Q, Kong H, Ng MHL, Chen C, He Y, Huang B, Yang M]
通讯作者: Yang M
DOI: 10.1016/j.thromres.2020.06.008
发表时间: 2020
期刊: Thrombosis Research
影响因子:
作者: [Zhang Yujiao, Zeng Xiaoyuan, Jiao Yingying, Li Zongpeng, Liu Qifa, Ye Jieyu, Yang Mo]
通讯作者: Yang Mo
DOI: 10.3892/mmr.2020.11653
发表时间: 2021-01-01
期刊: MOLECULAR MEDICINE REPORTS
影响因子: 3.4
作者: [Li, Liang, Xu, Wanhua, Yang, Mo]
通讯作者: Yang, Mo
6
    神经递质5-HT在巨核细胞/前血小板生成反馈调控中的分子机制
    • 批准号:
      81270580
    • 项目类别:
      面上项目
    • 资助金额:
      60.0万元
    • 批准年份:
      2012
    • 负责人:
      杨默
    • 依托单位:
    国内基金
    海外基金